ArticleFrontiers in cardiovascular medicine2024

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study.

Lucas Lage Marinho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.